In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies

SIMPLE SUMMARY: Despite a range of emerging immunotherapeutic strategies, the aggressive nature of DLBCL poses an ongoing clinical challenge. Therefore, there is a need to pursue more effective treatment modalities based on monoclonal antibodies, antibody-drug conjugates and CAR-T cell therapy. Up t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubacz, Matylda, Kusowska, Aleksandra, Winiarska, Magdalena, Bobrowicz, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818372/
https://www.ncbi.nlm.nih.gov/pubmed/36612228
http://dx.doi.org/10.3390/cancers15010235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818372/
https://www.ncbi.nlm.nih.gov/pubmed/36612228
http://dx.doi.org/10.3390/cancers15010235

Ejemplares similares